| |
| |
|
| Insider
Information: |
Higgins John L |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,806,928 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$48,630,171 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,806,928 |
|
|
| Total
Value |
$48,630,171 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
11
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -34.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
165 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-12-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,965 |
151,249 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,928 |
104,386 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,015 |
110,401 |
0 |
- |
|
| TECH |
Techne Corp |
|
– • – |
2018-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
514 |
3,526 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
13,646 |
129,258 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
12,809 |
138,899 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2019-10-24 |
4 |
A |
$0.00 |
$0 |
D/D |
495 |
4,021 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
13,614 |
156,562 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
13,559 |
210,289 |
0 |
- |
|
| TECH |
Techne Corp |
|
– • – |
2020-10-29 |
4 |
A |
$0.00 |
$0 |
D/D |
391 |
4,412 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-12-31 |
4 |
A |
$84.53 |
$18,851 |
D/D |
223 |
235,310 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
15,553 |
248,018 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,608 |
286,030 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-06-30 |
4 |
A |
$85.91 |
$21,220 |
D/D |
247 |
338,095 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
23,166 |
358,261 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-06-30 |
4 |
A |
$75.84 |
$12,437 |
D/D |
164 |
369,180 |
0 |
- |
|
| TECH |
Techne Corp |
|
– • – |
2022-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
338 |
5,840 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,176,521 |
2,176,521 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,922 |
424,731 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-11-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
2,427,861 |
2,603,965 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-12-28 |
4 |
A |
$3.66 |
$94,845 |
D/D |
25,914 |
2,397,255 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-01-04 |
4 |
A |
$3.23 |
$186,704 |
D/D |
57,803 |
2,339,452 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
39,517 |
2,462,686 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2023-10-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,625 |
36,608 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2013-10-18 |
4 |
AS |
$55.00 |
$550,000 |
D/D |
(10,000) |
106,581 |
0 |
- |
|
165 Records found
|
|
Page 2 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
